Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-eradication poliovirus facility-associated community risks.

Walter R Dowdle1, Chris Wolff

  • 1Task Force for Child Survival and Development, 750 Commerce Drive, Suite 400, Decatur, GA 30030, USA. wdowdle@taskforce.org

Biologicals : Journal of the International Association of Biological Standardization
|May 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking public health campaigns in the COVID-19 era: a call to improve effectiveness, equity and impact.

BMJ global health·2021
Same author

Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh.

The Journal of infectious diseases·2014
Same author

Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009.

The Journal of infectious diseases·2014
Same author

Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.

The Journal of infectious diseases·2014
Same author

Waning intestinal immunity after vaccination with oral poliovirus vaccines in India.

The Journal of infectious diseases·2012
Same author

The principles and feasibility of disease eradication.

Vaccine·2011

As global poliovirus use stops, preventing facility poliovirus transmission is key. Risk management strategies must address community exposure to wild poliovirus and Sabin strains, focusing on personnel and facility controls.

Area of Science:

  • Virology
  • Public Health
  • Risk Management

Background:

  • Global cessation of poliovirus use necessitates minimizing transmission risks from facilities to communities.
  • Community exposure to wild poliovirus and Sabin strains is primarily through potentially infected or contaminated facility personnel.
  • Current vaccines (oral poliovirus vaccine [OPV] and inactivated poliovirus vaccine [IPV]) prevent poliomyelitis but do not fully eliminate silent gut infections.

Purpose of the Study:

  • To assess community risks of poliovirus transmission from facilities post-OPV cessation.
  • To identify key transmission pathways and risk factors for community exposure.
  • To provide a foundation for effective risk management strategies.

Main Methods:

  • Evaluated community exposure risks via facility personnel, air effluent, and liquid effluents.

Related Experiment Videos

  • Considered the impact of environmental factors (relative humidity) on poliovirus survival.
  • Assessed the role of host immunity (circulating antibodies) in mitigating personnel infection risks.
  • Main Results:

    • Community exposure risks are highest from unknowingly contaminated or infected facility personnel.
    • Low relative humidity (<50%) may reduce poliovirus survival and inhalation risk.
    • Inhalation risk from air effluent is generally low in modern facilities, but ingestion risk from liquid effluents is facility-specific and variable.

    Conclusions:

    • Effective risk management requires a comprehensive assessment of facility-specific hazards, consequences of poliovirus transmission, and community exposure pathways.
    • Environmental controls and personnel immunity are important factors in reducing transmission.
    • Facility-specific risk assessments are crucial for managing community exposure to poliovirus post-OPV cessation.